(16 days)
In general, these devices are intended for use during cardiopulmonary bypass surgery for up to 6 hours. No changes were made to the intended use of the individual devices.
The Affinity CP Centrifugal Blood Pump with Carmeda BioActive Surface is used to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to 6 hours). It is also indicated for use in extracorporeal support systems (for periods up to 6 hours) not requiring complete cardiopulmonary bypass (eg, valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants).
The MYOtherm XP is a device intended for the mixing, warming/ cooling and delivery of oxygenated blood/cardioplegia solution in a predetermined ratio.
The Affinity Arterial Filter is indicated for use in cardiopulmonary bypass procedures up to 6 hours in duration for the removal of particulate and gaseous microemboli.
The Affinity NT Hollow Fiber Oxygenator with Plasma Resistant Fiber is intended to be used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood and to cool or warm the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.
The AFFINITY NT Integrated CVR Membrane Oxygenator (Plasma Resistant Fiber [PRF] Oxygenator) is intended to be used in an extracorporeal perfusion circuit to collect venous and cardiotomy suctioned blood, cool or warm the blood and oxygenate and remove carbon dioxide from the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.
This product, MVR Collapsible Venous Reservoir Bag, is indicated for use during cardiopulmonary bypass surgery in an extracorporeal circuit utilizing a membrane oxygenator. The MVR Holder (Model MVR-SH) is indicated for use with the MVR Collapsible Venous Reservoir Bag.
Medtronic Coated Accessories (Flow Probes) is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
Medtronic Coated Accessories (Tri-Optic Measurement Cells) is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
Medtronic Packs and Accessories (Tubing and Connectors) is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
The Medtronic Resting Heart Module is indicated for use in surgical procedures requiring extracorporeal circulatory support, gas exchange, and thermal regulation. The device is indicated for use in procedures requiring blood flow rate of 1-6 lpm and lasting up to six hours. The system is indicated for use only with the Bio-Console. The VARD is indicated for use only with the AAR1000. The Bio-Pump+ Blood Pump in the Medtronic Resting Heart Module is indicated for use only with the Bio-Console. The Carmeda AFFINITY NT Oxygenator and Carmeda AFFINITY Arterial Filter in the Medtronic Resting Heart Module have the same indications for use as a Carmeda AFFINITY NT Oxygenator and Carmeda AFFINITY Arterial Filter used in other extracorporeal circuits.
Medtronic DLP "Y" Adapter - Coronary Perfusion is intended for use in conjunction with the delivery of cardioplegia solution.
Medtronic DLP Aortic Root Cannula is intended for use in conjunction with cardiopulmonary bypass surgery for delivering cardioplegia solution. The cannula may also be used to aspirate air from the aorta at the conclusion of the bypass procedure. The #23009 cannula may also be used to monitor pressure in the aorta.
Medtronic EOPA 3D Arterial Cannula are intended for use in perfusion of the ascending aorta during short term (6 hours or less) cardiopulmonary bypass.
Medtronic DLP Single Stage Venous Cannula are intended for collection of venous blood from the right side of the heart via the superior and inferior vena cava during cardiopulmonary bypass surgery up to six hours or less.
Medtronic DLP Femoral Arterial and Venous Cannula is intended for rapid femoral venous and arterial access for short term cardiopulmonary bypass.
No changes to the devices are being made. An additional source of the raw material used to make USP heparin used in Carmeda and Trillium coatings is being added.
The provided text does NOT include details about a study evaluating a device's performance against acceptance criteria using AI or machine learning. Instead, it is a 510(k) summary for various Medtronic cardiopulmonary bypass devices, focusing on demonstrating substantial equivalence to predicate devices, primarily due to an additional source of raw material for heparin used in coatings.
Therefore, many of the requested sections (sample sizes for test and training sets, data provenance, expert adjudication, MRMC studies, standalone performance, ground truth types) cannot be fulfilled from the provided document as they relate to AI/ML device performance studies, which are not described here.
However, based on the text, I can infer the acceptance criteria and how the device (specifically, the modified heparin coating) meets them.
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria (Implied) | Reported Device Performance |
|---|---|
| Coating Performance: Maintain equivalent function and integrity of Carmeda and Trillium coatings with the new heparin raw material source. | "Testing demonstrates that there is no coating performance difference between the two sources of raw material for heparin." (Implicitly accepted if no difference is found). Coating testing was performed. |
| Potency of Heparin: Ensure the heparin retains its intended anticoagulant activity. | Potency of Heparin testing was conducted. (Implicitly accepted if results demonstrate equivalent potency to the current source and predicate devices.) |
| Chemistry: Ensure the new raw material does not introduce detrimental chemical changes or contaminants in the final product. | Chemistry testing was conducted. (Implicitly accepted if results demonstrate equivalent chemical profile and safety to the current source and predicate devices.) |
| Intended Use: The overall devices (e.g., blood pumps, oxygenators, filters) continue to meet their existing Indications for Use. | "No changes were made to the intended use of the individual devices." The current Indications for Use (up to 6 hours for most devices during cardiopulmonary bypass) are maintained, indicating the new raw material does not alter this. |
2. Sample size used for the test set and the data provenance:
- Sample Size for Test Set: Not specified. The document refers to "bench testing" but does not quantify the number of units or batches tested.
- Data Provenance: The testing appears to be internal Medtronic bench testing, likely conducted at their facilities in Minneapolis, MN, USA. It is prospective testing designed to evaluate the new raw material source.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable/Not specified. The "ground truth" for this type of performance testing (coating, chemistry, potency) would typically be established by established laboratory methods and validated instrumentation, overseen by qualified laboratory personnel and engineers, rather than expert consensus on clinical data.
4. Adjudication method for the test set:
- Not applicable/Not specified. Adjudication methods like 2+1 or 3+1 typically apply to clinical studies where reviewers (e.g., radiologists) are assessing images or clinical outcomes. For bench testing of material properties, performance is determined by adherence to pre-defined physical and chemical specifications.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No. This is not an AI/ML device, and no MRMC study was conducted or mentioned.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Not applicable. This is not an AI/ML algorithm. The performance described is for physical medical devices and their material properties.
7. The type of ground truth used:
- The "ground truth" would be the physical and chemical specifications and performance characteristics of the existing, predicate devices' heparin-coated components. The new raw material's performance was compared against these established benchmarks. This is essentially a comparison to a known standard/predicate device performance.
8. The sample size for the training set:
- Not applicable. There is no AI/ML training set. The "training" for this context would be the historical data and manufacturing processes of the existing heparin-coated devices.
9. How the ground truth for the training set was established:
- Not applicable. There is no AI/ML training set. The "ground truth" for the predicate devices' performance would have been established through their initial regulatory clearances, involving a combination of bench testing, biocompatibility studies, and potentially clinical data (though not explicitly detailed for the specific heparin coating formulation in this summary).
{0}------------------------------------------------
111912
JUL 2 7 2011
2 510(k) Summary
The following page contains the 510(k) Summary.
{1}------------------------------------------------
K III 972
Image /page/1/Picture/1 description: The image shows the Medtronic logo. On the left is a circular emblem with a figure in motion, possibly representing a person exercising or undergoing rehabilitation. To the right of the emblem is the word "Medtronic" in a bold, stylized font. The logo appears to be a representation of the company's focus on medical technology and improving health outcomes.
510(k) Summary
| Date Prepared: | July 6, 2011 |
|---|---|
| Submitter: | Medtronic7611 Northland DriveMinneapolis, MN 55428Establish Registration Number: 2184009 |
| Contact Person: | Jessica SixberrySenior Regulatory Affairs SpecialistPhone: (763) 514-9849Fax: (651) 367-1893Email: jessica.m.sixberry@medtronic.com |
Device Name and Classification:
| Product Family: | Centrifugal Blood Pumps |
|---|---|
| Trade Name: | Affinity Blood Pumps, Bio-Pumps |
| Common Name: | Centrifugal Blood Pump |
| Regulation Number: | 870.4360 |
| Product Code: | KFM |
| Classification: | Class III |
| Classification Name: | Pump, Blood, Cardiopulmonary Bypass, Non-Roller Type |
| Product Family: | MYOtherm Cardioplegia Delivery Systems |
|---|---|
| Trade Name: | MYOtherm Cardioplegia Delivery Systems |
| Common Name: | Cardioplegia Delivery |
| Regulation Number: | 870.4240 |
| Product Code: | DTR |
| Classification: | Class II |
| Classification Name: | Heat-Exchanger, Cardiopulmonary Bypass |
| Product Family: | Arterial Blood Filters |
|---|---|
| Trade Name: | Affinity Arterial Filters |
| Common Name: | Arterial Blood Filters |
| Regulation Number: | 870.4260 |
| Product Code: | DTM |
| Classification: | Class II |
| Classification Name: | Filter, Blood, Cardiopulmonary Bypass, Arterial Line |
Product Family: Oxygenators
Alleviating Pain · Restoring Health · Extending Life
{2}------------------------------------------------
のお気になる。
| Product Family: | Oxygenators |
|---|---|
| Trade Name: | Affinity NT Hollow Fiber Oxygenator with Plasma Resistant Fiber,Minimax Plus Oxygenator |
| Common Name: | Hollow Fiber Oxygenators |
| Regulation Number: | 870.4350 |
| Product Code: | DTZ |
| Classification: | Class II |
| Classification Name: | Oxygenator, Cardiopulmonary Bypass |
.. . . .
・
September 1998 - 1999 - 1999
*** -
| Product Family: | Cardiotomy/Venous Reservoirs |
|---|---|
| Trade Name: | Affinity Cardiotomy/Venous Reservoirs |
| Common Name: | Cardiotomy/Venous Reservoir |
| Regulation Number: | 870.4400 |
| Product Code: | DTN |
| Classification: | Class II |
| Classification Name: | Reservoir, Blood, Cardiopulmonary Bypass |
| Product Family: | Venous Reservoir Bags |
|---|---|
| Trade Name: | MVR Collapsible Venous Reservoir Bag |
| Common Name: | Venous Reservoir Bag |
| Regulation Number: | 870.4400 |
| Product Code: | DTN |
| Classification: | Class II |
| Classification Name: | Reservoir, Blood, Cardiopulmonary Bypass |
| Product Family: | Flow Probes |
|---|---|
| Trade Name: | Bio-Probe Flow Probe |
| Common Name: | Flow Probe |
| Regulation Number: | 870.2120 |
| Product Code: | DPT |
| Classification: | Class II |
| Classification Name: | Probe, Blood-Flow, Extravascular |
| Product Family: | Tri-Optic Measurement Cells |
|---|---|
| Trade Name: | Tri-Optic Measurement Cells |
| Common Name: | Tri-Optic Measurement Cells |
| Regulation Number: | 870.4330 |
| Product Code: | DRY |
| Classification: | Class II |
| Classification Name: | Monitor, Blood-Gas, On-line, Cardiopulmonary Bypass |
| Product Family: | Tubing and Connectors |
|---|---|
| ----------------- | ----------------------- |
{3}------------------------------------------------
K111912
.
| Product Family: | Tubing and Connectors |
|---|---|
| Trade Name: | Extracorporeal Circuit Tubing and Connectors |
| Common Name: | Tubing and Connectors |
| Regulation Number: | 870.4210 |
| Product Code: | DWF |
| Classification: | Class II |
| Classification Name: | Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass |
| Product Family: | Resting Heart System |
|---|---|
| Trade Name: | Resting Heart System |
| Common Name: | Low Prime Extracorporeal Circuit |
| Regulation Number: | 870.4400870.4290 |
| Product Code: | DTNDTL |
| Classification: | Class II |
| Classification Name: | Reservoir, blood, Cardiopulmonary BypassAdapter, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass |
| Product Family: | Cardioplegia Adapters |
|---|---|
| Trade Name: | DLP Cardioplegia Adapters |
| Common Name: | Cardioplegia Adapters |
| Regulation Number: | 870.7290 |
| Product Code: | DTL |
| Classification: | Class II |
| Classification Name: | Adapter, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass |
| Product Family: | Aortic Root Cannula |
| Trade Name: | DLP Aortic Root Cannula |
| Common Name: | Aortic Root Cannula |
| Regulation Number: | 870.4210 |
| Product Code: | DWF |
| Classification: | Class II |
| Classification Name: | Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass |
| Product Family: | Arterial Cannula |
|---|---|
| Trade Name: | DLP, Select, EOPA Arterial Cannula |
| Common Name: | Arterial Return Cannula |
| Regulation Number: | 870.4210 |
| Product Code: | DWF |
| Classification: | Class II |
| Classification Name: | Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass |
.
·
{4}------------------------------------------------
.. . . . . :
| Product Family: | Venous Cannula |
|---|---|
| Trade Name: | DLP, MC2, MC2X, Single Stage, Two Stage, Three Stage Cannula |
| Common Name: | Venous Cannula |
| Regulation Number: | 870.4210 |
| Product Code: | DWF |
| Classification: | Class II |
| Classification Name: | Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass |
| Product Family: | Femoral Cannula |
|---|---|
| Trade Name: | DLP and Bio-Medicus, Femoral Arterial and Femoral Venous Cannula |
| Common Name: | Femoral Cannula |
| Regulation Number: | 870.4210 |
| Product Code: | DWF |
| Classification: | Class II |
| Classification Name: | Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass |
:
Predicate Devices
| Product Family: | Associated 510(k)s |
|---|---|
| Centrifugal BloodPumps | K852807, K973011, K050109, K111658 |
| MYOthermCardioplegiaDelivery Systems | K003724, K011864 |
| Arterial Blood Filters | K000379, K013084, K033468, K071253 |
| Oxygenators | K933586, K973760, K000430 |
| Cardiotomy/VenousReservoirs | K926226, K936003, K021287 |
| Venous ReservoirBags | K920774 |
| Flow Probes | K830858, K012747 |
| Tri-OpticMeasurement Cells | K910421, K012743 |
| Tubing andConnectors | K891687, K902845, K012538 |
| Resting HeartSystem | K031700 |
| CardioplegiaAdapters | K790563, K790564, K791498, K841482, K850385 |
| Aortic Root Cannula | K790565, K810548, K834039, K865079 |
| Arterial Cannula | K840001, K840002, K031037, K031518, K033416, K043179,K061254 |
{5}------------------------------------------------
| Product Family: | Associated 510(k)s |
|---|---|
| Venous Cannula | K841275, K845045, K031776, K031827, K033264, K052372 |
| Femoral Cannula | K872033, K875353, K884129, K915268, K924642, K052524 |
Device Description
No changes to the devices are being made. An additional source of the raw material used to make USP heparin used in Carmeda and Trillium coatings is being added.
Indications for Use
In general, these devices are intended for use during cardiopulmonary bypass surgery for up to 6 hours. No changes were made to the intended use of the individual devices.
Comparison to Predicate Devices
- Intended Use: All devices have the same intended use as their predicate devices. .
- Principles of Operation and Technology: All devices have the same principle of . operation and technology as their predicate devices
- Performance: Testing demonstrates that there is no coating performance difference . between the two sources of raw material for heparin.
- Suppliers: The supplier of USP heparin remains the same. A new source of raw material . is being added.
Summary of Performance Data
Bench testing was used to establish the interchangability of the two sources of raw material for USP heparin used in Carmeda and Trillium coating. Animal and human clinical testing was not required to establish substantial equivalence. The following performance tests were conducted:
- . Coating testing
- Potency of Heparin .
- . Chemistry testing
Conclusion
Medtronic has demonstrated that the new source of raw material for heparin is interchangeable with the current source of raw material for heparin based upon testing results. Therefore, the Carmeda and Trillium coated devices are substantially equivalent to the existing, predicate devices.
{6}------------------------------------------------
Image /page/6/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle-like symbol with three curved lines representing the body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Medtronic Perfusion System c/o Ms. Jessica Sixberry Senior Regulatory Affairs Specialist 7611 Northland Drive Minneapolis, MN 55428
JUL 2 7 2011
Re: K111972
Affinity Blood Pumps, Bio-Pumps Regulation Number: 21 CFR 870.4360 Regulation Name: Non-roller type cardiopulmonary blood pump Regulatory Class: Class III (three) Product Code: KFM, DTR, DTM, DTZ, DTN, DPT, DRY, DWF, DTL Dated: July 7, 2011 Received: July 11, 2011
Dear Ms. Sixberry:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
{7}------------------------------------------------
Page 2 - Ms. Jessica Sixberry
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
K
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{8}------------------------------------------------
1 Statement of Indications for Use
The following page contains a representative 'indications for use' statement from each of the associated families that are included in this change. The following is a list of the associated families of Medtronic devices:
- . Centrifugal Blood Pumps
- MYOtherm Cardioplegia Delivery Systems .
- Arterial Blood Filters .
- . Oxygenators :
- . Cardiotomy/Venous Reservoirs
- Venous Reservoir Bags .
- Flow Probes .
- . Tri-Optic Measurement Cells
- . Tubing and Connectors
- . Resting Heart System
- . Cardioplegia Adapters
- . Aortic Root Cannula
- . Arterial Cannula
- Venous Cannula .
- Femoral Cannula ●
{9}------------------------------------------------
KIJ1972 510(k) Number (if known): _
Device Name: Affinity CP Centrifugal Blood Pump
Indications for Use: The Affinity CP Centrifugal Blood Pump with Carmeda BioActive Surface is used to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to 6 hours).
It is also indicated for use in extracorporeal support systems (for periods up to 6 hours) not requiring completecardiopulmonary bypass (eg, valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants).
Prescription Use X OR Per 21 CFR 801.109
Over-The-Counter Use ...
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
K
(Division Sign-Off) Division of Cardiovascular Devices
510(k) Number K111972
{10}------------------------------------------------
Device Name: Medtronic MYOtherm XP, Cardioplegia Delivery System
Indications for Use: The MYOtherm XP® is a device intended for the mixing, warming/ cooling and delivery of oxygenated blood/cardioplegia solution in a predetermined ratio.
Device Name: Affinity Arterial Filter
Indications for Use: The Affinity Arterial Filter is indicated for use in cardiopulmonary bypass procedures up to 6 hours in duration for the removal of particulate and gaseous microemboli.
Device Name: Affinity Hollow Fiber Oxygenator with Plasma Resistant Fiber
Indications for Use: The Affinity NT Hollow Fiber Oxygenator with Plasma Resistant Fiber is intended to be used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood and to cool or warm the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.
Device Name: Affinity NT Integrated CVR Membrane Oxygenator
Indications for Use: The AFFINITY® NT Integrated CVR Membrane Oxygenator (Plasma Resistant Fiber [PRF] Oxygenator) is intended to be used in an extracorporeal perfusion circuit to collect venous and cardiotomy suctioned blood, cool or warm the blood and oxygenate and remove carbon dioxide from the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.
Device Name: MVR Collapsible Venous Reservoir Bag
Indications for Use: This product, is indicated for use during cardiopulmonary bypass surgery in an extracorporeal circuit utilizing a membrane oxygenator. The MVR® Holder (Model MVR-SH) is indicated for use with the MVR® Collapsible Venous Reservoir Bag.
Device Name: Medtronic Coated Accessories (Flow Probes)
Indications for Use: This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
Device Name: Medtronic Coated Accessories (Tri-Optic Measurement Cells)
Indications for Use: This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
{11}------------------------------------------------
Device Name: Medtronic Packs and Accessories (Tubing and Connectors)
Indications for Use: This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
Device Name: Medtronic Resting Heart System
Indications for Use: The Medtronic® Resting Heart™ Module is indicated for use in surgical procedures requiring extracorporeal circulatory support, gas exchange, and thermal regulation. The device is indicated for use in procedures requiring blood flow rate of 1-6 lpm and lasting up to six hours. The system is indicated for use only with the Bio-Console®. The VARD is indicated for use only with the AAR1000. The Bio-Pump+® Blood Pump in the Medtronic® Resting Heart™ Module is indicated for use only with the Bio-Console®. The Carmeda® AFFINITY® NT Oxygenator and Carmeda® AFFINITY® Arterial Filter in the Medtronic® Resting Heart™ Module have the same indications for use as a Carmeda® AFFINITY® NT Oxygenator and Carmeda® AFFINITY® Arterial Filter used in other extracorporeal circuits.
Device Name: Medtronic DLP "Y" Adapter - Coronary Perfusion
Indications for Use: This adapter is intended for use in conjunction with the delivery of cardioplegia solution.
Device Name: Medtronic DLP Aortic Root Cannula
Indications for Use: This cannula is intended for use in conjunction with cardiopulmonary bypass surgery for delivering cardioplegia solution. The cannula may also be used to aspirate air from the aorta at the conclusion of the bypass procedure. The #23009 cannula may also be used to monitor pressure in the aorta.
Device Name: Medtronic EOPA 3D Arterial Cannula
Indications for Use: These cannulae are intended for use in perfusion of the ascending aorta during short term (6 hours or less) cardiopulmonary bypass.
Device Name: Medtronic DLP Single Stage Venous Cannula
Indications for Use: These cannulae are intended for collection of venous blood from the right side of the heart via the superior and inferior vena cava during cardiopulmonary bypass surgery up to six hours or less.
{12}------------------------------------------------
Device Name: Medtronic DLP Femoral Arterial and Venous Cannula
Indications for Use: This cannula is intended for rapid femoral venous and arterial access for short term cardiopulmonary bypass.
:
·
公司
§ 870.4360 Nonroller-type blood pump.
(a)
Nonroller-type cardiopulmonary and circulatory bypass blood pump —(1)Identification. A nonroller-type cardiopulmonary and circulatory bypass blood pump is a prescription device that uses a method other than revolving rollers to pump the blood through an extracorporeal circuit for periods lasting less than 6 hours for the purpose of providing either:(i) Full or partial cardiopulmonary bypass (
i.e., circuit includes an oxygenator) during open surgical procedures on the heart or great vessels; or(ii) Temporary circulatory bypass for diversion of flow around a planned disruption of the circulatory pathway necessary for open surgical procedures on the aorta or vena cava.
(2)
Classification —Class II (special controls). The special controls for this device are:(i) Non-clinical performance testing must perform as intended over the intended duration of use and demonstrate the following: Operating parameters, dynamic blood damage, heat generation, air entrapment, mechanical integrity, and durability/reliability;
(ii) The patient-contacting components of the device must be demonstrated to be biocompatible;
(iii) Sterility and shelf life testing must demonstrate the sterility of patient-contacting components and the shelf life of these components; and
(iv) Labeling must include information regarding the duration of use, and a detailed summary of the device- and procedure-related complications pertinent to use of the device.
(b)
Nonroller-type temporary ventricular support blood pump —(1)Identification. A nonroller-type temporary ventricular support blood pump is a prescription device that uses any method resulting in blood propulsion to provide the temporary ventricular assistance required for support of the systemic and/or pulmonary circulations during periods when there is ongoing or anticipated hemodynamic instability due to immediately reversible alterations in ventricular myocardial function resulting from mechanical or physiologic causes. Duration of use would be less than 6 hours.(2)
Classification. Class III (premarket approval).(c)
Date premarket approval application (PMA) or notice of completion of product development protocol (PDP) is required. A PMA or notice of completion of a PDP is required to be filed with FDA on or before September 8, 2015, for any nonroller-type temporary ventricular support blood pump that was in commercial distribution before May 28, 1976, or that has, on or before September 8, 2015, been found to be substantially equivalent to any nonroller-type temporary ventricular support blood pump that was in commercial distribution before May 28, 1976. Any other nonroller-type temporary ventricular support blood pump shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.